Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald F Klein

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 6, 2006
The flawed basis for FDA post-marketing safety decisions: the example of anti-depressants and childrenDonald F Klein
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 3, 2002
Improving scientific publications and public trust by data accessDonald F Klein
Archives of General Psychiatry|June 5, 2002
Response differences of spontaneous panic and fearDonald F Klein
The Journal of Clinical Psychiatry|September 13, 2006
FDA post-marketing safety decisionsDonald F Klein
Dialogues in Clinical Neuroscience|October 29, 2011
Historical aspects of anxietyDonald F Klein
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 4, 2007
Panic, suffocation false alarms, separation anxiety and endogenous opioidsMaurice Preter, Donald F Klein
Neurotoxicity Research|June 9, 2004
Genes and environment: nosology and psychiatryDonald F Klein, Jonathan Stewart
Neuroscience and Biobehavioral Reviews|April 15, 2014
Lifelong opioidergic vulnerability through early life separation: a recent extension of the false suffocation alarm theory of panic disorderMaurice Preter, Donald F Klein
JAMA|July 20, 2007
Improving detection of adverse effects of marketed drugsDonald F Klein, Charles P O'Brien
The Journal of Clinical Endocrinology and Metabolism|December 8, 2004
AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual functionStuart N Seidman, Donald F Klein
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 6, 2006
The flawed basis for FDA post-marketing safety decisions: the example of anti-depressants and childrenDonald F Klein
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 3, 2002
Improving scientific publications and public trust by data accessDonald F Klein
Archives of General Psychiatry|June 5, 2002
Response differences of spontaneous panic and fearDonald F Klein
The Journal of Clinical Psychiatry|September 13, 2006
FDA post-marketing safety decisionsDonald F Klein
Dialogues in Clinical Neuroscience|October 29, 2011
Historical aspects of anxietyDonald F Klein
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 4, 2007
Panic, suffocation false alarms, separation anxiety and endogenous opioidsMaurice Preter, Donald F Klein
Neurotoxicity Research|June 9, 2004
Genes and environment: nosology and psychiatryDonald F Klein, Jonathan Stewart
Neuroscience and Biobehavioral Reviews|April 15, 2014
Lifelong opioidergic vulnerability through early life separation: a recent extension of the false suffocation alarm theory of panic disorderMaurice Preter, Donald F Klein
JAMA|July 20, 2007
Improving detection of adverse effects of marketed drugsDonald F Klein, Charles P O'Brien
The Journal of Clinical Endocrinology and Metabolism|December 8, 2004
AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual functionStuart N Seidman, Donald F Klein
Pageof 7